Loading...
•
Jul 31, 2024
Engene Q3 2024 Earnings Report
Reported financial results for the third quarter ended July 31, 2024.
Key Takeaways
enGene Holdings Inc. announced its financial results for the third quarter ended July 31, 2024. The company's cash and cash equivalents were $257.7 million as of July 31, 2024, and expects this to fund operations into 2027. Net loss attributable to common shareholders was approximately $14.1 million, or $0.32 per share.
Cash and cash equivalents of $257.7 million provide runway into 2027.
Total operating expenses were $16.8 million for the three months ended July 31, 2024, compared to $6.2 million for the three months ended July 31, 2023.
Net loss attributable to common shareholders was approximately $14.1 million, or $0.32 per share, compared to approximately $6.0 million, or $8.55 per share, for the same period for the three months ended July 31, 2023.
Company remains on track to report preliminary LEGEND data in September 2024
Engene
Engene
Forward Guidance
enGene expects to release preliminary data from the LEGEND study’s pivotal BCG-unresponsive cohort by the end of September and expects that its existing cash and cash equivalents will fund operating expenses, debt obligations and capital expenditures into 2027.